BackgroundResistance to platinum-based drugs represents a major obstacle for the management of high-grade serous ovarian cancer (HGSOC) patients. Indeed, the selective pressure of platinum-based (PT) chemotherapy often leads to the outgrowth of platinum-resistant subclones. In this scenario, the underlying adaptive networks should be fully investigated to provide advances toward more streamlined and personalized care.MethodsWe conducted a comprehensive analysis of Pin1/Notch3relationship from HGSOC cell lines and primary tumours, integrating multiple genetic targeting under chemotherapy pressure, differential proteomic approaches, molecular docking data and dynamics simulations, thus identifying a functional circuit evaluated in vitro and in vivo models.We conducted a comprehensive analysis of relationship from HGSOC cell lines and primary tumours, integrating multiple genetic targeting under chemotherapy pressure, differential proteomic approaches, molecular docking data and dynamics simulations, thus identifying a functional circuit evaluated in vitro and in vivo models.ResultsHere, we demonstrated that carboplatin treatment of HGSOC cells promoted the activation of the Pin1/Notch3 axis, resulting in platinum resistance. Accordingly, HGSOC-bearing patients showing increased Pin1/Notch3 co-expression after PT-based chemotherapy correlated with a clinical worse response. Conversely, genetic targeting of Pin1 combined with carboplatin treatment sensitizes resistant cells to platinum-based therapy, both in vitro and in vivo, strongly reducing their Notch3-mediated metastatic potential in preclinical murine models. Mechanistically, Pin1-Notch3 binding favours protection of Notch3 from its GSK3 beta-mediated degradation, resulting in increased Notch3 expression.ConclusionsCollectively, our findings identify the functional Pin1/Notch3 axis as an escape strategy from chemotherapy-induced cell death, thus suggesting a novel predictive role of the Pin1/Notch3 axis in the platinum response, which could be useful for implementing frontline treatments for HGSOC patients before recurrence.
Prolyl-isomerase Pin1 drives platinum resistance by regulating Notch3 stability and function in ovarian cancer / Giuli, Maria Valeria; Mancusi, Angelica; Natiello, Bianca; Di Cristofano, Samuele; Reali, Rebecca; Pignataro, Maria Gemma; D'Andrea, Daniel; Di Magno, Laura; Nicoletti, Carmine; Giorgi, Alessandra; Macone, Alberto; Camerini, Serena; Casella, Marialuisa; Peruzzi, Giovanna; Zema, Sabrina; Canettieri, Gianluca; Tomao, Federica; Palaia, Innocenza; Pernazza, Angelina; Rustighi, Alessandra; Palermo, Rocco; Raimondo, Domenico; Monti, Alessandra; Doti, Nunzianna; D'Amati, Giulia; Del Sal, Giannino; Screpanti, Isabella; Talora, Claudio; Bellavia, Diana; Checquolo, Saula. - In: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. - ISSN 1756-9966. - 45:1(2026). [10.1186/s13046-026-03658-x]
Prolyl-isomerase Pin1 drives platinum resistance by regulating Notch3 stability and function in ovarian cancer
Giuli, Maria ValeriaPrimo
;Mancusi, Angelica;Natiello, Bianca;Di Cristofano, Samuele;Reali, Rebecca;Pignataro, Maria Gemma;Di Magno, Laura;Nicoletti, Carmine;Giorgi, Alessandra;Macone, Alberto;Peruzzi, Giovanna;Zema, Sabrina;Canettieri, Gianluca;Tomao, Federica;Palaia, Innocenza;Pernazza, Angelina;Palermo, Rocco;Raimondo, Domenico;Monti, Alessandra;d'Amati, Giulia;Del Sal, Giannino;Screpanti, Isabella;Talora, Claudio
;Bellavia, Diana;Checquolo, Saula
Ultimo
2026
Abstract
BackgroundResistance to platinum-based drugs represents a major obstacle for the management of high-grade serous ovarian cancer (HGSOC) patients. Indeed, the selective pressure of platinum-based (PT) chemotherapy often leads to the outgrowth of platinum-resistant subclones. In this scenario, the underlying adaptive networks should be fully investigated to provide advances toward more streamlined and personalized care.MethodsWe conducted a comprehensive analysis of Pin1/Notch3relationship from HGSOC cell lines and primary tumours, integrating multiple genetic targeting under chemotherapy pressure, differential proteomic approaches, molecular docking data and dynamics simulations, thus identifying a functional circuit evaluated in vitro and in vivo models.We conducted a comprehensive analysis of relationship from HGSOC cell lines and primary tumours, integrating multiple genetic targeting under chemotherapy pressure, differential proteomic approaches, molecular docking data and dynamics simulations, thus identifying a functional circuit evaluated in vitro and in vivo models.ResultsHere, we demonstrated that carboplatin treatment of HGSOC cells promoted the activation of the Pin1/Notch3 axis, resulting in platinum resistance. Accordingly, HGSOC-bearing patients showing increased Pin1/Notch3 co-expression after PT-based chemotherapy correlated with a clinical worse response. Conversely, genetic targeting of Pin1 combined with carboplatin treatment sensitizes resistant cells to platinum-based therapy, both in vitro and in vivo, strongly reducing their Notch3-mediated metastatic potential in preclinical murine models. Mechanistically, Pin1-Notch3 binding favours protection of Notch3 from its GSK3 beta-mediated degradation, resulting in increased Notch3 expression.ConclusionsCollectively, our findings identify the functional Pin1/Notch3 axis as an escape strategy from chemotherapy-induced cell death, thus suggesting a novel predictive role of the Pin1/Notch3 axis in the platinum response, which could be useful for implementing frontline treatments for HGSOC patients before recurrence.| File | Dimensione | Formato | |
|---|---|---|---|
|
Giuli_Prolyl-isomerase_2026.pdf
accesso aperto
Note: Articolo in rivista
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
3.55 MB
Formato
Adobe PDF
|
3.55 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


